With the ever-increasing pressure on pharmaceutical and biotechnology companies to bring more products to market faster while also cutting costs, many in the industry have turned their focus to streamlining study start-ups. With an estimated 65% of FDA-regulated clinical trials running outside of the US, these factors become globally important.
While some factors, such as regulatory and ethical approval processes and patient demographics, are outside of a sponsor’s direct control, there are strategies sponsors can implement to positively impact start-up timelines.
Register now for this upcoming interactive webcast: February 14 at 2:00 pm EST.
Tenley Koepnick, Clinipace’s Director of Global Site Management Services, will provide sponsors and site management personnel with practical advice and strategies for streamlining start-up for global studies. Participants will learn best practices for:
- Embracing planning and preparation
- Clearly spelling out eligibility/ineligibility criteria
- Researching selected sites
- Streamlining protocols
- Providing assistance for IRB/EC submissions
Registration is free. Register now.